Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05742685 · ClinicalTrials.gov registry record · NA

Refinement and Adaption of Reinforcement Learning to Personalize Behavioral Messaging for Healthy Habits

A NA study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
28
Enrollment target

NCT05742685 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 28 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05742685, a NA study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

Reinforcement learning is an advanced analytic method that discovers each individual's pattern of responsiveness by observing their actions and then implements a personalized strategy to optimize individuals' behaviors using trial and error. The goal of the proposed research is to refine, adapt and perform efficacy testing of a novel reinforcement learning-based text messaging intervention to support medication adherence for patients with type 2 diabetes within a community health center setting. This study will be a parallel randomized pragmatic trial comparing medication adherence and clinical outcomes for adults in a community setting aged 18-84 with type 2 diabetes who are prescribed 1-3 daily oral medications for this disease. Participants will be randomized to one of two arms for the duration of the study period: (1) a reinforcement learning intervention arm with up to daily, tailored text messages based on time-varying treatment-response patterns; or (2) a control arm with up to daily, un-tailored text messages. Outcomes of interest will be medication adherence, as measured by electronic pill bottles, and HbA1c levels over 6 months.

Interventions

  • BEHAVIORAL Reinforcement Learning

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2023-08-23
Est. Completion 2025-12-17
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT05742685

The ClinicalTrials.gov registry entry for NCT05742685 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Reinforcement Learning is the first listed.

NCT05742685 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05742685 about?

NCT05742685 is a clinical study titled "Refinement and Adaption of Reinforcement Learning to Personalize Behavioral Messaging for Healthy Habits". Reinforcement learning is an advanced analytic method that discovers each individual's pattern of responsiveness by observing their actions and then implements a personalized strategy to optimize individuals' behaviors using trial and error. The goal of the proposed research is to refine, adapt and ...

What is the current status of trial NCT05742685?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2023-08-23. Estimated completion is 2025-12-17.

What interventions are being tested in trial NCT05742685?

The interventions under investigation include: Reinforcement Learning (BEHAVIORAL).

Who is sponsoring clinical trial NCT05742685?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.